Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 2
1988 1
1990 3
1991 5
1992 2
1993 5
1994 1
1995 2
1996 4
1997 5
1998 8
1999 8
2000 6
2001 9
2002 11
2003 7
2004 5
2005 6
2006 5
2007 6
2008 4
2009 2
2010 5
2011 4
2012 2
2013 4
2014 1
2015 3
2016 8
2017 2
2019 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Nanosensors for cancer detection.
Huber F, Lang HP, Zhang J, Rimoldi D, Gerber C. Huber F, et al. Among authors: rimoldi d. Swiss Med Wkly. 2015 Feb 9;145:w14092. doi: 10.4414/smw.2015.14092. eCollection 2015. Swiss Med Wkly. 2015. PMID: 25664868 Free article. Review.
Melanoma-associated antigens.
Carrel S, Rimoldi D. Carrel S, et al. Among authors: rimoldi d. Eur J Cancer. 1993;29A(13):1903-7. doi: 10.1016/0959-8049(93)90548-t. Eur J Cancer. 1993. PMID: 8260252 Review. No abstract available.
Genomic and transcriptomic landscape of conjunctival melanoma.
Cisarova K, Folcher M, El Zaoui I, Pescini-Gobert R, Peter VG, Royer-Bertrand B, Zografos L, Schalenbourg A, Nicolas M, Rimoldi D, Leyvraz S, Riggi N, Moulin AP, Rivolta C. Cisarova K, et al. Among authors: rimoldi d. PLoS Genet. 2020 Dec 31;16(12):e1009201. doi: 10.1371/journal.pgen.1009201. eCollection 2020 Dec. PLoS Genet. 2020. PMID: 33383577 Free PMC article.
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Romero P, Valmori D, Pittet MJ, Zippelius A, Rimoldi D, Lévy F, Dutoit V, Ayyoub M, Rubio-Godoy V, Michielin O, Guillaume P, Batard P, Luescher IF, Lejeune F, Liénard D, Rufer N, Dietrich PY, Speiser DE, Cerottini JC. Romero P, et al. Among authors: rimoldi d. Immunol Rev. 2002 Oct;188:81-96. doi: 10.1034/j.1600-065x.2002.18808.x. Immunol Rev. 2002. PMID: 12445283 Review.
Frequent MAGE mutations in human melanoma.
Caballero OL, Zhao Q, Rimoldi D, Stevenson BJ, Svobodová S, Devalle S, Röhrig UF, Pagotto A, Michielin O, Speiser D, Wolchok JD, Liu C, Pejovic T, Odunsi K, Brasseur F, Van den Eynde BJ, Old LJ, Lu X, Cebon J, Strausberg RL, Simpson AJ. Caballero OL, et al. Among authors: rimoldi d. PLoS One. 2010 Sep 16;5(9):e12773. doi: 10.1371/journal.pone.0012773. PLoS One. 2010. PMID: 20862285 Free PMC article.
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.
El Zaoui I, Bucher M, Rimoldi D, Nicolas M, Kaya G, Pescini Gobert R, Bedoni N, Schalenbourg A, Sakina E, Zografos L, Leyvraz S, Riggi N, Rivolta C, Moulin AP. El Zaoui I, et al. Among authors: rimoldi d. Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2764-2772. doi: 10.1167/iovs.18-26508. Invest Ophthalmol Vis Sci. 2019. PMID: 31247083
135 results